Red and processed meat not associated with colon cancer re-occurence

Publicly released:
International
Photo by Leonardo Carvalho on Unsplash
Photo by Leonardo Carvalho on Unsplash

Consuming red meat and processed meats may not increase the risk of death from recurrence of colon cancer, according to international research. Red and processed meats have been consistently linked to increased cancer risk, the researchers say, leading to advice against eating too much of it for those who have already had cancer. However, the researchers recruited a cohort of about 1000 people with stage III colon cancer and tracked their outcomes over an average of six and a half years compared with their red and processed meat intake. Of the patients who died or saw a recurrence of their cancer, the researchers say there was no increased risk for those who ate more red and processed meats.

Media release

From: JAMA

What The Study Did: In this observational study examining self-reported dietary behavior of 1,011 patients with stage III colon cancer, eating either unprocessed red meat or processed meat after diagnosis wasn’t significantly associated with risk of colon cancer recurrence or mortality.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research JAMA, Web page The URL will go live after the embargo ends
Journal/
conference:
JAMA Network Open
Research:Paper
Organisation/s: University of California San Francisco, USA
Funder: Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Numbers U10CA180821 and U10CA180882 (to the Alliance for Clinical Trials in Oncology); U10CA032291, U10CA041287, U10CA045808, U10CA077651, U10CA138561, U10CA180791, and U10CA180820 (to ECOG-ACRIN Cancer Research Group); U10CA180836, U10CA180867, and U10CA180888 (to SWOG Cancer Research Network); UG1CA189858 (to the Southeast Clinical Oncology Research Consortium, Inc); K07CA197077 (to Dr Van Blarigan); R01CA118553 (to Dr Fuchs); and R35CA197735 (to Dr Ogino). Dr Meyerhardt’s research is supported by the Douglas GrayWoodruff Chair fund, the Guo Shu Shi Fund, Anonymous Family Fund for Innovations in Colorectal Cancer, Project P fund, and the George Stone Family Foundation.
Media Contact/s
Contact details are only visible to registered journalists.